Amanda McCann
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Oncology top 2%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
Papers in
-
- Epigenetics and DNA Methylation 18
- Extracellular vesicles in disease 11
- Glycosylation and Glycoproteins Research 6
- Protein Degradation and Inhibitors 5
- Genomics and Chromatin Dynamics 5
-
- MicroRNA in disease regulation 10
- Co-authors
- Desmond N. Carney (3 shared papers)P. Dervan (17 shared papers)Jenny Watson (8 shared papers)John A. Baugh (4 shared papers)Chris Watson (3 shared papers)Fiona Furlong (12 shared papers)Matthew Ho (8 shared papers)Karolina Weiner‐Gorzel (6 shared papers)
- Journals
- Human Molecular Genetics (3 papers)Epigenetics (3 papers)Cancers (3 papers)British Journal of Cancer (3 papers)Human Pathology (3 papers)
- Partner nations
- IrelandUnited KingdomUnited States
In The Last Decade
Amanda McCann
84 papers receiving 3.7k citations
Amanda McCann's Hit Papers
Peers
Comparison fields: 5 of 142
- Cancer Research 869
- Oncology 988
- Molecular Biology 2.1k
- Cell Biology 356
- Genetics 449
Countries citing papers authored by Amanda McCann
This map shows the geographic impact of Amanda McCann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda McCann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda McCann more than expected).
Fields of papers citing papers by Amanda McCann
This network shows the impact of papers produced by Amanda McCann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda McCann. The network helps show where Amanda McCann may publish in the future.
Co-authors
The 25 scholars most cited alongside Amanda McCann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 441 | |
| 2 | The fate of chemoresistance in triple negative breast cancer (TNBC) Hit paper breakdown → | 2015 | 312 |
| 3 | 2013 | 224 | |
| 4 | 2007 | 160 | |
| 5 | Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer. | 1991 | 152 |
| 6 | 2015 | 134 | |
| 7 | 2010 | 133 | |
| 8 | 1990 | 125 | |
| 9 | 2008 | 107 | |
| 10 | 1995 | 104 | |
| 11 | 1995 | 99 | |
| 12 | 2019 | 91 | |
| 13 | 2007 | 88 | |
| 14 | 2009 | 84 | |
| 15 | 2017 | 81 | |
| 16 | Frequent loss of imprinting of PEG1/MEST in invasive breast cancer. | 1999 | 80 |
| 17 | 2014 | 70 | |
| 18 | 2011 | 67 | |
| 19 | 2003 | 65 | |
| 20 | 2011 | 58 |
About Amanda McCann
Amanda McCann is a scholar working on Molecular Biology, Cancer Research, Oncology, Genetics and Cell Biology, having authored 86 papers that have together received 3.8k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (18 papers), Extracellular vesicles in disease (11 papers), MicroRNA in disease regulation (10 papers), Glycosylation and Glycoproteins Research (6 papers), Microtubule and mitosis dynamics (5 papers), HER2/EGFR in Cancer Research (5 papers), Protein Degradation and Inhibitors (5 papers) and Genomics and Chromatin Dynamics (5 papers). The work is most often cited by research in Cancer Research (869 citations), Oncology (988 citations), Molecular Biology (2.1k citations), Cell Biology (356 citations) and Genetics (449 citations). Amanda McCann has collaborated with scholars based in Ireland, United Kingdom and United States. Frequent co-authors include Desmond N. Carney, P. Dervan, Jenny Watson, John A. Baugh, Chris Watson, Fiona Furlong, Matthew Ho, Karolina Weiner‐Gorzel, Luke Gubbins and Malcolm Kell. Their work appears in journals such as Human Molecular Genetics, Epigenetics, Cancers, British Journal of Cancer and Human Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.